Portal field news

Portal field news

in ,

📢 | Taiho Pharmaceutical's own drug discovery, Fuchibatinib, is a breakthrough therapy finger from the FDA as a treatment for advanced bile duct cancer ...


写真 

Taiho Pharmaceutical's in-house drug discovery, Fuchibatinib, is a breakthrough therapy finger from the FDA as a treatment for advanced bile duct cancer ...

 
If you write the contents roughly
The designated criterion is to provide preliminary clinical evidence that there is potential for significant improvement in at least one clinically meaningful endpoint compared to existing treatments.
 

April 2021, 4 Taiho Pharmaceutical Co., Ltd. Taiho Oncology, Inc. Taiho Pharmaceutical Co., Ltd.… → Continue reading

 Kyodo News PR Wire

Kyodo PR wire, which distributes press releases and news releases, connects information from "who wants to know" to "people who want to know."
This is a site that consumers should pay attention to, where news releases from major governments and government agencies including local governments and universities are gathered.


Wikipedia related words

If there is no explanation, there is no corresponding item on Wikipedia.

Existing treatment

Designation criteria


 

Back to Top
Close